Bumper Offer - Urjas oil Just @ Rs. 1
Ibclop A 75/150 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Ibclop A 75/150 Capsule is used -
Severe
Moderate
Mild
Common
Is the use of Ibclop A 75/150 Capsule safe for pregnant women?
Ibclop A may have some side effects during pregnancy. Pregnant women should discontinue the use of Ibclop A, and talk to their doctor, if they notice any discomfort.
Is the use of Ibclop A 75/150 Capsule safe during breastfeeding?
Breastfeeding women can take Ibclop A as it bears very minor side effects for them.
What is the effect of Ibclop A 75/150 Capsule on the Kidneys?
Very few cases of side effects of Ibclop A on kidney have been reported.
What is the effect of Ibclop A 75/150 Capsule on the Liver?
Ibclop A can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ibclop A 75/150 Capsule on the Heart?
Ibclop A is rarely harmful for the heart.
Ibclop A 75/150 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Ibclop A 75/150 Capsule unless your doctor advises you to do so -
Is this Ibclop A 75/150 Capsule habit forming or addictive?
Ibclop A 75/150 Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Ibclop A 75/150 Capsule since it will not make you feel sleepy.
Is it safe?
Yes, Ibclop A 75/150 Capsule is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Ibclop A 75/150 Capsule for mental disorders.
Interaction between Food and Ibclop A 75/150 Capsule
Taking Ibclop A 75/150 Capsule with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ibclop A 75/150 Capsule
Information about the interaction of Ibclop A 75/150 Capsule and alcohol is not currently available because this topic has not been researched yet.
Ibclop A primarily relieves pain because it is an analgesic. It also reduces inflammations (swellings) arising due to injuries and infections in the body. Apart from being an analgesic, it works by preventing strokes and other heart-related disorders by, the blood and reducing thromboxane (a chemical) responsible for making the platelets sticky. Hence by this action, it prevents blood clots which further prevents strokes and heart blockages.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Yes, Ibclop A is used as an anticoagulant (blood thinner ) because low doses of this medicine have been effective in preventing brain and heart-related disorders such as myocardial infarction (heart attack) and strokes.
No, Ibclop A does not cause sleepiness because prescribed Ibclop A has no effect on the central nervous system but an overdose of Ibclop A may lead to seizures, cerebral edema, coma, confusion, and dizziness.
No, Ibclop A is not banned in India. It has been approved by CDSCO.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
